BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35023929)

  • 1. Successful Treatment of Primary CNS Extranodal NK/T-Cell Lymphoma with Surgery and Chemotherapy Combined with Sintilimab: A Case Report and Literature Review.
    Qin L; Li Y; He Y; Zeng R; Pan T; Zuo Y; Xiao L; Zhou H
    Onco Targets Ther; 2022; 15():1-11. PubMed ID: 35023929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extranodal natural killer/T-cell lymphoma invading a patient's heart: A rare case report and literature review.
    Xiang Y; Lin X; Cai X; Qu S; Lin KY
    Front Oncol; 2022; 12():1011894. PubMed ID: 36568165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical analysis of patients with primary and secondary extranodal natural killer/T-cell lymphoma of central nervous system.
    Li X; Yu H; Fu X; Zhang L; Li X; Li L; Wang X; Sun Z; Zhang X; Li Z; Wu J; Chang Y; Yan J; Zhou Z; Nan F; Wu X; Tian L; Zhang M
    Hematol Oncol; 2023 Apr; 41(2):267-274. PubMed ID: 34061378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, with Primary Manifestation as an Upper Eyelid Swelling.
    Kanzaki A; Funasaka Y; Nakamizo M; Shima A; Ryotokuji T; Dan K; Terasaki M; Sugisaki Y; Fukuda Y; Kawana S; Saeki H
    J Nippon Med Sch; 2016; 83(4):177-9. PubMed ID: 27680487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary central nervous system extranodal NK/T-cell lymphoma, nasal type with CD20 expression: Case report and review of the literature.
    Guan J; Lin W; Liu W; Hui D
    Neuropathology; 2024 Jun; 44(3):222-229. PubMed ID: 37963650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary natural killer/T-cell lymphoma presenting as leptomeningeal disease.
    Liao B; Kamiya-Matsuoka C; Gong Y; Chen M; Wolf BA; Fowler NH
    J Neurol Sci; 2014 Aug; 343(1-2):46-50. PubMed ID: 24880537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
    Adabifirouzjaei F; Khazai B; Azami G; Shoja-E-Razavi G
    J Med Case Rep; 2021 Oct; 15(1):539. PubMed ID: 34702349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined immune checkpoint blockade and radiotherapy induces durable remission in relapsed natural killer/T-cell lymphoma: a case report and review of the literature.
    McGehee E; Patel H; Pearson C; Clements K; Jaso JM; Chen W; Callan A; Desai N; Ramakrishnan Geethakumari P
    J Med Case Rep; 2021 Apr; 15(1):221. PubMed ID: 33926575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary central nervous system extranodal NK/T-cell lymphoma, nasal type: case report and review of the literature.
    Guan H; Huang Y; Wen W; Xu M; Zan Q; Zhang Z
    J Neurooncol; 2011 Jun; 103(2):387-91. PubMed ID: 20845062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma.
    Nevel KS; Pentsova E; Daras M
    Leuk Lymphoma; 2019 Jul; 60(7):1677-1684. PubMed ID: 30648449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary central nervous system extranodal nasal-type natural killer/T-cell lymphoma with CD20 expression.
    Li D; Fu F; Lian L
    Neuropathology; 2018 Apr; 38(2):198-204. PubMed ID: 29063643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological analysis of primary central nervous system NK/T cell lymphoma: rare and localized aggressive tumour among extranasal NK/T cell tumours.
    Miyata-Takata T; Takata K; Kato S; Hu LM; Noujima-Harada M; Chuang SS; Sato Y; Maeda Y; Yoshino T
    Histopathology; 2017 Aug; 71(2):287-295. PubMed ID: 28342197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
    Kim SJ; Oh SY; Hong JY; Chang MH; Lee DH; Huh J; Ko YH; Ahn YC; Kim HJ; Suh C; Kim K; Kim WS
    Ann Oncol; 2010 May; 21(5):1058-63. PubMed ID: 19850636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.
    Ding H; Chang J; Liu LG; Hu D; Zhang WH; Yan Y; Ma LY; Li ZC; Ma YJ; Hao SG; Tao R
    Int J Hematol; 2015 Aug; 102(2):181-7. PubMed ID: 25997870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous Involvement of Extranodal NK/T Cell Lymphoma, Nasal Type, a Clinical and Histopathological Mimicker of Various Skin Diseases.
    Ngamdamrongkiat P; Sukpanichnant S; Chairatchaneeboon M; Khuhapinant A; Sitthinamsuwan P
    Dermatopathology (Basel); 2022 Sep; 9(3):307-320. PubMed ID: 36135102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extranodal Natural Killer/T-cell Lymphoma in a Child with a Prior History of Nasal Trauma: a Case Report.
    Aloosi SN; Ali SM; Mohammed VF; Mahmud PK; Hassan HA
    Adv J Emerg Med; 2018; 2(3):e34. PubMed ID: 31172097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atezolizumab in combination with intrathecal chemotherapy and radiation for treatment of isolated cerebral nervous system relapse in a patient with extranodal NK/T cell lymphoma: a case report.
    Lipsitt AE; Hung JY; Langevin AM
    J Med Case Rep; 2021 Mar; 15(1):102. PubMed ID: 33663601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Abscess as a Rare Complication of Primary Extranodal Nasal-type Natural Killer/T-cell Lymphoma.
    Ohta N; Waki T; Ito T; Suzuki Y; Kakehata S; Aoyagi M
    Yonago Acta Med; 2020 Feb; 63(1):88-91. PubMed ID: 32158338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary spinal natural killer/T-cell lymphoma successfully treated with concurrent chemoradiotherapy and autologous stem cell transplantation.
    Kim KT; Kim YB; Kim HJ; Cha YJ; Lee SJ; Park E
    Spine (Phila Pa 1976); 2012 May; 37(10):E629-32. PubMed ID: 22089400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.